Literature DB >> 12215610

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Richard C Pasternak, Sidney C Smith, C Noel Bairey-Merz, Scott M Grundy, James I Cleeman, Claude Lenfant.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12215610     DOI： 10.1161/01.str.0000034125.94759.41

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  39 in total

1.  Coenzyme Q(10) and statin myalgia: what is the evidence?

Authors:  Emilie Mas; Trevor A Mori
Journal:  Curr Atheroscler Rep       Date:  2010-11       Impact factor: 5.113

Review 2.  [Lipid lowering drug and other toxic myopathies].

Authors:  B G H Schoser; D Pongratz
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

3.  Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

Authors:  Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

Review 4.  Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

Authors:  Roberto Scarpioni; Marco Ricardi; Vittorio Albertazzi; Luigi Melfa
Journal:  World J Nephrol       Date:  2012-12-06

5.  Rhabdomyolysis-induced compartment syndrome secondary to atorvastatin and strenuous exercise.

Authors:  Louise Dunphy; Rossel Morhij; Sarah Tucker
Journal:  BMJ Case Rep       Date:  2017-03-16

Review 6.  Mechanisms and assessment of statin-related muscular adverse effects.

Authors:  Dirk Moßhammer; Elke Schaeffeler; Matthias Schwab; Klaus Mörike
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

7.  Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.

Authors:  T A Ashfield; H E Syddall; H J Martin; E M Dennison; C Cooper; A Aihie Sayer
Journal:  Age Ageing       Date:  2009-12-17       Impact factor: 10.668

8.  Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.

Authors:  Paul S Phillips; Theodore P Ciaraldi; Dong-Lim Kim; M Anthony Verity; Tanya Wolfson; Robert R Henry
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

9.  Pharmacogenomic insights into treatment and management of statin-induced myopathy.

Authors:  Bas Jm Peters; Olaf H Klungel; Frank L Visseren; Anthonius de Boer; Anke-Hilse Maitland-van der Zee
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

10.  The efficacy and safety of ezetimibe and low-dose simvastatin as a primary treatment for dyslipidemia in renal transplant recipients.

Authors:  Hye Eun Yoon; Joon Chang Song; Bok Jin Hyoung; Hyeon Seok Hwang; So Young Lee; Youn Joo Jeon; Bum Soon Choi; Yong Soo Kim; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 3.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.